- Home
- PYPD vs TRIB Comparison
PYPD vs TRIB Comparison
Compare PYPD & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- TRIB
- Stock Information
- Founded
- PYPD 2008
- TRIB 1992
- Country
- PYPD Israel
- TRIB Ireland
- Employees
- PYPD N/A
- TRIB N/A
- Industry
- PYPD Medical/Dental Instruments
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PYPD Health Care
- TRIB Health Care
- Exchange
- PYPD Nasdaq
- TRIB Nasdaq
- Market Cap
- PYPD 30.1M
- TRIB 25.5M
- IPO Year
- PYPD 2020
- TRIB N/A
- Fundamental
- Price
- PYPD $2.99
- TRIB $0.77
- Analyst Decision
- PYPD Strong Buy
- TRIB
- Analyst Count
- PYPD 2
- TRIB 0
- Target Price
- PYPD $10.50
- TRIB N/A
- AVG Volume (30 Days)
- PYPD 18.1K
- TRIB 6.3M
- Earning Date
- PYPD 02-12-2025
- TRIB 04-03-2025
- Dividend Yield
- PYPD N/A
- TRIB N/A
- EPS Growth
- PYPD N/A
- TRIB N/A
- EPS
- PYPD N/A
- TRIB N/A
- Revenue
- PYPD N/A
- TRIB $59,126,000.00
- Revenue This Year
- PYPD N/A
- TRIB $11.63
- Revenue Next Year
- PYPD N/A
- TRIB $10.13
- P/E Ratio
- PYPD N/A
- TRIB N/A
- Revenue Growth
- PYPD N/A
- TRIB N/A
- 52 Week Low
- PYPD $2.37
- TRIB $0.73
- 52 Week High
- PYPD $6.58
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- PYPD 49.42
- TRIB 43.29
- Support Level
- PYPD $2.89
- TRIB $0.73
- Resistance Level
- PYPD $3.27
- TRIB $0.82
- Average True Range (ATR)
- PYPD 0.28
- TRIB 0.06
- MACD
- PYPD 0.00
- TRIB -0.01
- Stochastic Oscillator
- PYPD 45.89
- TRIB 14.77
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.